References
- Slag MF, Morley JE, Elson MK, et al. Impotence in medical clinic outpatients. JAMA 1983: 249(13): 1736–40
- Federman DD. The assessment of Organ function—the testis. N Engl J Med 1971:285(16): 901–3
- Smith KD, Tcholakian RE, Chowdhury M, et al. Rapid oscillations in plasma levels of testosterone, luteinizing hormone, and follicle-stimulating hormone in men. Fertil Steril 1974: 25(11): 965–75
- Spark RF. Neuroendocrtnology and Impotence. Ann Intern Med 1983: 98(1): 103–5
- Van Arsdalen KN, Wein AJ. Drug-induced sexual dysfunction in older men. Geriatrics 1984: 39(10): 63–7.70
- Brogden RN, Heel RL, Speight TM, et al. Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension. Drugs 1977: 163–97
- Zorgniotti AW, Lefleur RS. Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. J Urol 1985: 133(1): 39–41
- Padma-Nathan H, Goldstein I, Krane RJ. Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy. Semin Urol 1986: 4(4): 236–8
- Benson GS, McConnell J, Lipshultz LI, et al. Neuromorphology and neuropharmacology of the human penis: an in vitro study. J Clin Invest 1980: 65(2): 506–13
- Morales A, Surridge DH, Marshall PG, et al. Nonhormonal pharmacological treatment of organic impotence. J Urol 1982: 128(1): 45–7